Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. - Wikidata - thesis-toulmin - TriplyDB

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

http://www.wikidata.org/entity/Q34733901

about

Impact of Aspiration Pneumonia on the Clinical Course of Progressive Supranuclear Palsy: A Retrospective Cohort Study Rotenone, paraquat, and Parkinson's disease C9orf72 repeat expansions are a rare genetic cause of parkinsonism Regional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementia Cholinesterase inhibitors for rarer dementias associated with neurological conditions Cholinesterase inhibitors for neurological conditions associated with rarer dementias Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech.Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study Clinical Approach to Progressive Supranuclear Palsy Genetics of Progressive Supranuclear Palsy Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature Three sib-pairs of autopsy-confirmed progressive supranuclear palsy.Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech.Electrophysiological evaluation of oropharyngeal Dysphagia in Parkinson's disease Key emerging issues in progressive supranuclear palsy and corticobasal degeneration Concomitant pathologies among a spectrum of parkinsonian disorders The Differential Diagnosis and Treatment of Atypical Parkinsonism Chronic traumatic encephalopathy and other neurodegenerative proteinopathies The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier)Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.Parkinson disease loci in the mid-western Amish Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.Frontotemporal Dementia.Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy.Automatic Evaluation of Speech Rhythm Instability and Acceleration in Dysarthrias Associated with Basal Ganglia Dysfunction The effect of the serotonin transporter polymorphism (5-HTTLPR) on empathic and self-conscious emotional reactivity.Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.Sound naming in neurodegenerative disease.Detecting sarcasm from paralinguistic cues: anatomic and cognitive correlates in neurodegenerative disease.Progressive supranuclear palsy.EMG responses to free fall in elderly subjects and akinetic rigid patients.Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort.Distinctive features of saccadic intrusions and microsaccades in progressive supranuclear palsy Phosphorylated α-synuclein in Parkinson's disease.Primary lateral sclerosis as progressive supranuclear palsy: diagnosis by diffusion tensor imaging.Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease Progressive supranuclear palsy: high-field-strength MR microscopy in the human substantia nigra and globus pallidus.

P2860

Q21131719-32CBF1FC-B157-4B9E-ACBF-449D2B6130A2 Q22241595-D0A25211-FAFF-4886-AA08-3D3D0550E714 Q23936600-A322D898-9673-4104-B7D4-C28B4F63D3E4 Q24186916-A7CB6D57-830F-4D67-9F8D-DA6A70C2F9B4 Q24187428-79395B64-F79A-493B-BFE5-15F7D18722D7 Q24201472-0C2489C5-CE55-4060-A408-B408C8713852 Q24597126-38727302-713D-4852-B90A-2CB7B5669FD7 Q24630410-B3D95EA8-ACEE-450F-BDD6-C66CE4B31E98 Q24632112-26862086-5F61-4C35-BBF7-86BFDFE0BF08 Q24655620-5B962D68-9489-437A-8CB3-25138DDBAD24 Q26772944-BB429F90-1061-4915-A11E-7A2FE516C992 Q26785904-587238CF-4DA7-428E-B319-AAF2C5B93992 Q26801152-EA28B6EA-A677-4B0F-95A0-2F5F0D5F33A3 Q27304645-573BA5F1-4018-4C42-B24E-D10B03582727 Q27317202-343B85FA-978F-4BE5-8EB8-AA496959815C Q27674993-6014D08B-E496-4826-8D67-0D3BA29452B6 Q28084976-A2311294-D268-4C7C-9F24-999EB8D3913B Q28236077-F8BA73B2-84D2-4CA5-8E2A-F3813831B0FF Q28273551-B6A03D1C-6383-4422-B099-4B86CE60A000 Q28395193-57A88937-56E4-407A-A526-C61D695193D1 Q28485924-810A3662-FE48-40DA-8684-B060F82AFD57 Q28538079-1773A4AC-C90D-426F-98C8-B17A90A05EFC Q28553194-BBD00BDF-904B-4DE7-976F-DA757274E744 Q28943294-4087EB83-91BA-4D7F-81B7-C2AA20AAB23E Q29417026-61A5D038-C9A6-4408-AB54-AA42F90F07F8 Q30234793-DA5D6A4D-6A42-4563-9361-F6431ACA07DA Q30306088-B40DF23D-705B-4EA0-8B56-E925531C7CEB Q30405128-EC06997C-C698-4F76-8E66-3498B3827111 Q30443529-CFC3B2D1-20C5-44F8-8B48-1AAA5F5CED17 Q30454798-28BDE24E-E90A-49CF-AD33-FFAEDAF124EC Q30475999-E721E465-0F01-4550-81C4-EB901441CF66 Q30479402-817456EE-6318-4691-9901-48869D1714BF Q30493367-ACEE2391-CE8F-4767-BFDB-3983955CB56C Q30495656-F60AC78C-8D2C-4137-A724-F329E3DB9D65 Q30499904-DE5F5FD2-52E3-4F53-B208-C060154D371F Q30500965-39C6A730-94A5-479F-A398-3A012572C35B Q30510167-34A6564F-27A4-4551-A428-ED1F591CBA9F Q30518016-E8A0491C-39D4-4CB5-B258-21DDC605456A Q30529759-F9004C08-5B25-4A90-9BEB-409D87EF4E16 Q30577479-A1D2D2F5-59EF-4C09-B3F0-E6E5D96E969D

P2860

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

http://www.wikidata.org/entity/Q34733901

description

1996 nî lūn-bûn

@nan

1996 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Clinical research criteria for ...... S-SPSP international workshop.

@ast

Clinical research criteria for ...... S-SPSP international workshop.

@en

Clinical research criteria for the diagnosis of progressive supranuclear palsy

@nl

type

label

Clinical research criteria for ...... S-SPSP international workshop.

@ast

Clinical research criteria for ...... S-SPSP international workshop.

@en

Clinical research criteria for the diagnosis of progressive supranuclear palsy

@nl

prefLabel

Clinical research criteria for ...... S-SPSP international workshop.

@ast

Clinical research criteria for ...... S-SPSP international workshop.

@en

Clinical research criteria for the diagnosis of progressive supranuclear palsy

@nl

P1433

Q34733901-997A8979-2F10-47FC-AF00-7C7EA961D8C1

P1476

Q34733901-4443EE36-431D-420D-B85A-22C144B0287F

P2093

Q34733901-000C7BC3-3292-44B8-8756-46C3464416E2

Q34733901-0BC98F4B-60E3-45C8-8D9C-5FF529A9F13C

Q34733901-66ED6E01-93CF-4610-9BC5-5B12E70A5A57

Q34733901-770423DC-557F-4197-A639-A4D6F747F7E3

Q34733901-7A4D0A6E-5E52-4521-895C-492EB3B9F3D2

Q34733901-7E5B2920-EA99-4510-93B2-C74A5160F0CE

Q34733901-A3CFBF11-8098-4302-A758-0480E5E67C15

Q34733901-A77858BF-C4D0-44F4-AEA7-1CB71AC48BFD

Q34733901-A946CB54-7BC4-4C17-81B0-27927359C156

Q34733901-BE6637EA-93BC-4E47-931E-C857382DC9EA

P304

Q34733901-19E767DF-B7F8-4ED0-8E44-E9E1FB1498DC

P31

Q34733901-01406F26-5CA8-4C1C-948F-4A9B8544798A

P356

Q34733901-1A9221DF-059D-4F20-A20E-00BE98720A56

P407

Q34733901-52CCB9D4-58C7-4B23-9B74-A30A69DC3E09

P433

Q34733901-70CC0AC0-FECF-4C4B-B0EE-9FEF6AE316CC

P478

Q34733901-86E74EDB-D865-4E0E-8660-D02E8F414C14

P50

Q34733901-C4343CBF-0FBC-49E3-8C5B-8D45492A0C2D

P577

Q34733901-417A690D-8638-4C78-A03B-F55FEF2BDB51

P698

Q34733901-4E5D2CB3-6DFD-424F-80FE-3809C4F8EE10

P921

Q34733901-DF59978B-5331-4447-802B-0C4406CA9352

Q34733901-eddb2524-e3ce-40b2-96c5-e736e04c57a7

P356

P1433

P1476

Clinical research criteria for ...... S-SPSP international workshop.

@en

P2093

Calne D

http://www.w3.org/2001/XMLSchema#string

Campbell G

http://www.w3.org/2001/XMLSchema#string

Dubois B

http://www.w3.org/2001/XMLSchema#string

Duvoisin RC

http://www.w3.org/2001/XMLSchema#string

Goetz CG

http://www.w3.org/2001/XMLSchema#string

Golbe LI

http://www.w3.org/2001/XMLSchema#string

Grafman J

http://www.w3.org/2001/XMLSchema#string

Growdon JH

http://www.w3.org/2001/XMLSchema#string

Hallett M

http://www.w3.org/2001/XMLSchema#string

Jankovic J

http://www.w3.org/2001/XMLSchema#string

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.47.1.1

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

P577

1996-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8710059

http://www.w3.org/2001/XMLSchema#string

P921